Scynexis (SCYX) EBT Margin (2013 - 2025)

Scynexis (SCYX) posted EBT Margin of 65.74% for Q4 2025, up 102.56% on a QoQ basis from 2572.16% in Q3 2025, and up 51712.0% year-over-year from N/an in Q4 2024.

Scynexis (SCYX) EBT Margin (2013 - 2025) Analysis & Trends

Scynexis' EBT Margin history runs 12 years deep, the most recent figure standing at 65.74% for Q4 2025.

  • Quarterly EBT Margin rose 51712.0% year-over-year to 65.74% in Q4 2025, while the trailing twelve-month figure through Mar 2026 was 96.57% (up 94761.0% YoY) and the FY2025 annual result came in at 41.79%, up 52247.0% from the prior year.
  • EBT Margin was 65.74% for Q4 2025 at Scynexis, up from 2572.16% in the prior quarter.
  • Across five years, EBT Margin topped out at 93.01% in Q2 2023 and bottomed at 4906.03% in Q4 2021.
  • A 5-year average of 1139.41% and a median of 504.77% in 2025 frame the typical range for EBT Margin.
  • Annual changes were most pronounced in 2022 — EBT Margin surged 395984 bps — and 2025, when it tumbled 216627 bps.
  • Scynexis' EBT Margin stood at 4906.03% in 2021, then jumped by 81 bps to 946.19% in 2022, then soared by 65 bps to 335.12% in 2023, then sank by 35 bps to 451.38% in 2024, then surged by 115 bps to 65.74% in 2025.
  • Business Quant data shows SCYX's EBT Margin at 65.74% in Q4 2025, 2572.16% in Q3 2025, and 504.77% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 10.97%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 33.51%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -41.57%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 40.73%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -7.05%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 30.30%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.35%
10 Scynexis 21.55 Mn -15.20 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 65.74%
Sep 30, 2025 -2,572.16%
Jun 30, 2025 -504.77%
Mar 31, 2025 -2,097.67%
Dec 31, 2024 -451.38%
Sep 30, 2024 -485.30%
Jun 30, 2024 -1,964.40%
Mar 31, 2024 68.61%
Dec 31, 2023 -335.12%
Sep 30, 2023 -99.77%
Jun 30, 2023 93.01%
Mar 31, 2023 -2,997.88%
Dec 31, 2022 -946.19%
Sep 30, 2022 -1,900.06%
Jun 30, 2022 -1,008.69%
Mar 31, 2022 -1,450.14%
Dec 31, 2021 -4,906.03%
Sep 30, 2021 -126.94%
Mar 31, 2021 -29.68%
Jun 30, 2019 -14,742.11%